Katsunori Tanaka

Affiliations: 
Kwansei Gakuin University, Nishinomiya-shi, Hyōgo-ken, Japan 
Area:
DNA replication checkpoint
Google:
"Katsunori Tanaka"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Nasibullin I, Smirnov I, Ahmadi P, et al. (2022) Synthetic prodrug design enables biocatalytic activation in mice to elicit tumor growth suppression. Nature Communications. 13: 39
Ikegami T, Kise N, Kinjyo H, et al. (2021) Development of Antibodies against HPV-6 and HPV-11 for the Study of Laryngeal Papilloma. Viruses. 13
Ahmadi P, Muguruma K, Chang TC, et al. (2021) metal-catalyzed SeCT therapy by a proapoptotic peptide. Chemical Science. 12: 12266-12273
Pradipta AR, Tanaka K. (2021) Biofunctional chemistry and reactivity of biogenic acrolein for cancer diagnosis and therapy. Chemical Communications (Cambridge, England). 57: 9798-9806
Kunitomi R, Pradipta AR, Kawabe H, et al. (2021) Inhibition of amyloid formation of amyloid β (1-42), amylin and insulin by 1,5-diazacyclooctanes, a spermine-acrolein conjugate. Bioorganic & Medicinal Chemistry. 46: 116391
Yamamoto T, Chang TC, Tanaka K. (2021) Epoc group: transformable protecting group with gold(iii)-catalyzed fluorene formation. Chemical Science. 12: 10703-10709
Chang TC, Tanaka K. (2021) In vivo organic synthesis by metal catalysts. Bioorganic & Medicinal Chemistry. 46: 116353
Fujiki K, Tanaka K. (2021) Biomolecular labeling based on lysine-clickable 6π-azaelectrocyclization toward innovative cancer theranostics. Bioorganic & Medicinal Chemistry. 42: 116238
Akutsu N, Sasaki S, Matsui T, et al. (2021) Association of the Low-density Lipoprotein Cholesterol/High-density Lipoprotein Cholesterol Ratio with Glecaprevir-pibrentasvir Treatment. Internal Medicine (Tokyo, Japan)
Vong K, Tahara T, Urano S, et al. (2021) Disrupting tumor onset and growth via selective cell tagging (SeCT) therapy. Science Advances. 7
See more...